American Academy of Allergy Asthma & Immunology Annual Meeting
The phase 3 BORA trial evaluated the safety and efficacy of an asthma treatment among 86 adolescents for up to 3 years.
The ACAAI and AAAAI task force recently released new practice parameters for administering the influenza vaccine to patients with egg allergies.
The American Academy of Allergy, Asthma, and Immunology and American College of Allergy, Asthma, and Immunology have released new guidelines for the initial treatment of seasonal allergic rhinitis with pharmacological therapies.
Researchers revealed the results of the highly anticipated trial of Viaskin, a peanut-allergy skin patch.